Direkt zum Inhalt
Merck
  • Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators.

Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators.

Clinical chemistry (1996-12-01)
N P Dudman, X W Guo, R Crooks, L Xie, J S Silberberg
ZUSAMMENFASSUNG

The recognition of homocysteine as a vascular risk factor has led to increased clinical interest in assaying plasma homocysteine concentrations. Our aim was to improve the reliability of a widely used assay based on HPLC of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid (SBD) derivative. We found that SBD derivatives of homocysteine, cysteine, and N-acetylhomocysteine were highly unstable in light but essentially stable in the dark for several hours at either 0 degree C or 25 degrees C. As our primary calibrator, we chose homocystine added to human serum for more consistent results than homocysteine or homocystine in an aqueous buffer. N-acetylcysteine was effective as an internal recovery standard. We observed a previously unreported peak with a prolonged elution time in some plasma samples from subjects who had ingested methionine. Our findings suggest improvements in this and other assay procedures for plasma homocysteine.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
7-Fluorbenzofurazan-4-sulfonsäure Ammoniumsalz, ≥98%
Supelco
7-Fluorbenzofurazan-4-sulfonsäure Ammoniumsalz, for HPLC derivatization, LiChropur, ≥98.5% (HPLC)